Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Total KLA Stockholders’ Equity
Common Stock and Capital in Excess of Par Value, Shares
Common Stock and Capital in Excess of Par Value, Amount
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non- Controlling Interest
Beginning balance (in shares) at Jun. 30, 2022     141,804        
Beginning balance at Jun. 30, 2022 $ 1,399,090 $ 1,401,351   $ 1,061,940 $ 366,882 $ (27,471) $ (2,261)
Increase (Decrease) in Stockholders' Equity              
Net income 1,025,991 1,025,991     1,025,991    
Net income attributable to non-controlling interest 74           74
Other comprehensive income (loss) (31,370) (31,370)       (31,370)  
Net issuance under employee stock plans (in shares)     171        
Net issuance under employee stock plans (54,950) (54,950)   (54,950)      
Repurchase of common stock (in shares)     (257)        
Repurchase of common stock (89,616) (89,616)   (1,926) (87,690)    
Cash dividends and dividend equivalents declared (186,216) (186,216)     (186,216)    
Stock-based compensation expense 34,982 34,982   34,982      
Purchase of non-controlling interest (4,294) 1,902   1,902     (6,196)
Disposal of non-controlling interest 8,383           8,383
Ending balance (in shares) at Sep. 30, 2022     141,718        
Ending balance at Sep. 30, 2022 2,102,074 2,102,074   1,041,948 1,118,967 (58,841) 0
Beginning balance (in shares) at Jun. 30, 2022     141,804        
Beginning balance at Jun. 30, 2022 1,399,090 1,401,351   1,061,940 366,882 (27,471) (2,261)
Increase (Decrease) in Stockholders' Equity              
Net income 2,702,623            
Net income attributable to non-controlling interest 74            
Other comprehensive income (loss) $ (7,820)            
Repurchase of common stock (in shares) (4,913)            
Ending balance (in shares) at Mar. 31, 2023     137,289        
Ending balance at Mar. 31, 2023 $ 2,682,781 2,682,781   1,996,773 721,299 (35,291) 0
Beginning balance (in shares) at Sep. 30, 2022     141,718        
Beginning balance at Sep. 30, 2022 2,102,074 2,102,074   1,041,948 1,118,967 (58,841) 0
Increase (Decrease) in Stockholders' Equity              
Net income 978,795 978,795     978,795    
Other comprehensive income (loss) 9,739 9,739       9,739  
Net issuance under employee stock plans (in shares)     170        
Net issuance under employee stock plans 31,196 31,196   31,196      
Repurchase of common stock (in shares)     (3,429)        
Repurchase of common stock (370,982) (370,982)   870,811 (1,241,793)    
Cash dividends and dividend equivalents declared (185,967) (185,967)     (185,967)    
Stock-based compensation expense 38,405 38,405   38,405      
Ending balance (in shares) at Dec. 31, 2022     138,459        
Ending balance at Dec. 31, 2022 2,603,260 2,603,260   1,982,360 670,002 (49,102) 0
Increase (Decrease) in Stockholders' Equity              
Net income 697,837 697,837     697,837    
Net income attributable to non-controlling interest 0            
Other comprehensive income (loss) 13,811 13,811       13,811  
Net issuance under employee stock plans (in shares)     57        
Net issuance under employee stock plans $ (16,154) (16,154)   (16,154)      
Repurchase of common stock (in shares) (1,227)   (1,227)        
Repurchase of common stock $ (482,712) (482,712)   (17,563) (465,149)    
Cash dividends and dividend equivalents declared (181,391) (181,391)     (181,391)    
Stock-based compensation expense 48,130 48,130   48,130      
Ending balance (in shares) at Mar. 31, 2023     137,289        
Ending balance at Mar. 31, 2023 2,682,781 2,682,781   1,996,773 721,299 (35,291) 0
Beginning balance (in shares) at Jun. 30, 2023     136,750        
Beginning balance at Jun. 30, 2023 2,919,753 2,919,753   2,107,663 848,431 (36,341) 0
Increase (Decrease) in Stockholders' Equity              
Net income 741,375 741,375     741,375    
Other comprehensive income (loss) (13,097) (13,097)       (13,097)  
Net issuance under employee stock plans (in shares)     173        
Net issuance under employee stock plans (68,237) (68,237)   (68,237)      
Repurchase of common stock (in shares)     (956)        
Repurchase of common stock (459,093) (459,093)   (14,722) (444,371)    
Cash dividends and dividend equivalents declared (179,256) (179,256)     (179,256)    
Stock-based compensation expense 48,772 48,772   48,772      
Ending balance (in shares) at Sep. 30, 2023     135,967        
Ending balance at Sep. 30, 2023 2,990,217 2,990,217   2,073,476 966,179 (49,438) 0
Beginning balance (in shares) at Jun. 30, 2023     136,750        
Beginning balance at Jun. 30, 2023 2,919,753 2,919,753   2,107,663 848,431 (36,341) 0
Increase (Decrease) in Stockholders' Equity              
Net income 1,925,450            
Net income attributable to non-controlling interest 0            
Other comprehensive income (loss) $ (5,179)            
Repurchase of common stock (in shares) (2,392)            
Repurchase of common stock $ (1,276,352)            
Ending balance (in shares) at Mar. 31, 2024     134,713        
Ending balance at Mar. 31, 2024 3,094,885 3,094,885   2,177,501 958,904 (41,520) 0
Beginning balance (in shares) at Sep. 30, 2023     135,967        
Beginning balance at Sep. 30, 2023 2,990,217 2,990,217   2,073,476 966,179 (49,438) 0
Increase (Decrease) in Stockholders' Equity              
Net income 582,534 582,534     582,534    
Other comprehensive income (loss) 17,174 17,174       17,174  
Net issuance under employee stock plans (in shares)     141        
Net issuance under employee stock plans 45,427 45,427   45,427      
Repurchase of common stock (in shares)     (848)        
Repurchase of common stock (441,563) (441,563)   (13,014) (428,549)    
Cash dividends and dividend equivalents declared (198,698) (198,698)     (198,698)    
Stock-based compensation expense 48,620 48,620   48,620      
Ending balance (in shares) at Dec. 31, 2023     135,260        
Ending balance at Dec. 31, 2023 3,043,711 3,043,711   2,154,509 921,466 (32,264) 0
Increase (Decrease) in Stockholders' Equity              
Net income 601,541 601,541     601,541    
Net income attributable to non-controlling interest 0            
Other comprehensive income (loss) (9,256) (9,256)       (9,256)  
Net issuance under employee stock plans (in shares)     41        
Net issuance under employee stock plans $ (24,275) (24,275)   (24,275)      
Repurchase of common stock (in shares) (588)   (588)        
Repurchase of common stock $ (375,696) (375,696)   (9,415) (366,281)    
Cash dividends and dividend equivalents declared (197,822) (197,822)     (197,822)    
Stock-based compensation expense 56,682 56,682   56,682      
Ending balance (in shares) at Mar. 31, 2024     134,713        
Ending balance at Mar. 31, 2024 $ 3,094,885 $ 3,094,885   $ 2,177,501 $ 958,904 $ (41,520) $ 0